PrimeCare Systems, Inc. (PCYS) — Análisis de acciones con IA
Solo con fines informativos. No es asesoramiento financiero.
Cotizando a $0.00001, PrimeCare Systems, Inc. (PCYS) es una empresa de Cuidado de la salud valorada en .
PrimeCare Systems, Inc. se especializa en el desarrollo y la comercialización de sistemas de gestión de pacientes principalmente en los Estados Unidos.
La compañía ofrece PrimeCare Version Ten, un sistema de gestión de pacientes de múltiples niveles, y CodeComplierJ, un programa de software de aplicación que calcula los códigos de reembolso.
Descripción general de la empresa
Resumen:
¿Qué hace PCYS?
¿Cuál es la tesis de inversión de PCYS?
¿En qué industria opera PCYS?
¿Cuáles son las oportunidades de crecimiento de PCYS?
- Expansion of Web-Based Services: PrimeCare Systems can leverage its existing websites, such as PrimeCareOnTheWeb.com and YourOwnHealth.com, to offer enhanced services like telehealth consultations, remote patient monitoring, and online health education programs. The telehealth market is projected to reach $55.6 billion by 2027, presenting a significant opportunity for PrimeCare to generate new revenue streams and expand its customer base. Timeline: Within the next 2-3 years.
- Strategic Partnerships with Healthcare Providers: Collaborating with hospitals, clinics, and physician groups can provide PrimeCare Systems with access to a broader customer base and accelerate the adoption of its patient management systems. By integrating its software with existing healthcare workflows, PrimeCare can improve efficiency and reduce administrative burdens for healthcare providers. Timeline: Ongoing.
- Development of Mobile Applications: Creating mobile applications for both healthcare providers and patients can enhance accessibility and convenience, enabling users to access patient data, schedule appointments, and communicate with healthcare professionals on the go. The mobile health market is expected to reach $254 billion by 2026, driven by the increasing adoption of smartphones and wearable devices. Timeline: Within the next 1-2 years.
- Focus on At-Risk Healthcare Entities: PrimeCare Systems' strategy of selling directly to at-risk healthcare entities, such as correctional facilities and military organizations, presents a unique growth opportunity. These organizations often require specialized patient management systems to address their specific needs, providing PrimeCare with a niche market to target. Timeline: Ongoing.
- Leveraging Data Analytics: By incorporating data analytics capabilities into its patient management systems, PrimeCare Systems can provide healthcare providers with valuable insights into patient outcomes, treatment effectiveness, and cost optimization. The healthcare analytics market is projected to reach $50.5 billion by 2027, driven by the increasing demand for data-driven decision-making in healthcare. Timeline: Within the next 2-3 years.
- Market capitalization of $0.00B indicates a micro-cap company with limited resources.
- Negative P/E ratio of -0.00 reflects the company's current lack of profitability.
- Profit margin of -1441.0% signals significant financial challenges and operational inefficiencies.
- Gross margin of -343.1% indicates that the company's cost of revenue exceeds its revenue, raising concerns about its business model.
- Beta of 0.73 suggests the stock is less volatile than the overall market.
¿Qué productos y servicios ofrece PCYS?
- Develop and market patient management systems.
- Offer PrimeCare Version Ten, a multi-tier patient management system.
- Provide CodeComplierJ, an application software for reimbursement code calculation.
- Create and maintain websites for healthcare providers and patients.
- Target national and local health care systems, military organizations, and correctional facilities.
- Offer web-based services through PrimeCareOnTheWeb.com, YourOwnDoctor.com, and YourOwnHealth.com.
- Focus on direct sales to at-risk healthcare entities.
¿Cómo gana dinero PCYS?
- Direct sales of patient management software to healthcare providers.
- Subscription fees for access to web-based services.
- Revenue from private labeling opportunities.
- Sales through distributors.
- National and local health care systems
- Military organizations
- Correctional facilities
- Hospitals with outpatient services
- Ambulatory/outpatient medical facilities
- Clinics, group practices, and solo practitioners
- Specialized software solutions tailored to specific healthcare needs.
- Established relationships with at-risk healthcare entities.
- Proprietary websites and online platforms for patient and provider interaction.
- CodeComplierJ application software for reimbursement code calculation.
¿Qué podría impulsar al alza las acciones de PCYS?
- Ongoing: Expansion of web-based services and telehealth offerings.
- Ongoing: Strategic partnerships with healthcare providers.
- Upcoming: Development of mobile applications for healthcare providers and patients.
- Ongoing: Focus on at-risk healthcare entities to drive sales.
- Upcoming: Integration of data analytics capabilities into patient management systems.
¿Cuáles son los riesgos clave de PCYS?
- Ongoing: Negative profit and gross margins raise concerns about financial sustainability.
- Ongoing: Competition from larger, more established companies in the healthcare information services market.
- Potential: Changes in healthcare regulations and reimbursement policies.
- Potential: Economic downturn affecting healthcare spending.
- Ongoing: Cybersecurity risks and data breaches affecting patient data.
¿Cuáles son las fortalezas clave de PCYS?
- Specialized patient management software.
- Established websites for healthcare providers and patients.
- Direct sales approach to at-risk healthcare entities.
- Proprietary CodeComplierJ application.
¿Cuáles son las debilidades de PCYS?
- Negative profit and gross margins.
- Small size and limited resources.
- OTC listing with potential liquidity constraints.
- Dependence on a limited number of products and services.
Perfil de la Empresa
- CEO: Robert A. Shiver
- Sede Central: Newport News, US
- Empleados: 8
- Año de la OPI: 2008
Perspectiva de la IA
- OTC Tier: OTC Other
- Disclosure Status: Unknown
¿Quiénes son los competidores de PCYS?
PCYS se compara a continuación con 8 pares del sector en precio, capitalización y nuestro MoonshotScore de IA.
| Empresa | Precio | Cambio | Capitalización de Mercado | Puntuacion AI |
|---|---|---|---|---|
| CMHSF Comprehensive Healthcare Systems, Inc. | $0.3119 | +0.00% | $5.62M | 55 |
| CRBKF Carebook Technologies Inc. | $0.028 | +0.00% | $6.84M | 64 |
| CMPD CompuMed, Inc. | $7.25 | -7.70% | $9.35M | 60 |
| BBLN Babylon Holdings Limited | $0.5504 | -13.99% | $14.1M | 56 |
| THKKF Think Research Corporation | $0.226 | -1.74% | $17.8M | 57 |
| AKLI Akili, Inc. | $0.4331 | +0.25% | $34.1M | 67 |
| AIRDF Rocket Doctor AI Inc. | $0.438 | -2.99% | $42.4M | 56 |
| VRHI Veri Medtech Holdings Inc. | $2.35 | +0.00% | $46.9M | 67 |
Puntuación IA por Stock Expert AI · Datos de precio: FMP / Yahoo Finance
Preguntas y respuestas
What does PrimeCare Systems, Inc. do?
PrimeCare Systems, Inc. se especializa en el desarrollo y la comercialización de sistemas de gestión de pacientes principalmente en los Estados Unidos.
La compañía ofrece PrimeCare Version Ten, un sistema de gestión de pacientes de múltiples niveles, y CodeComplierJ, un programa de software de aplicación que calcula los códigos de reembolso.
What do analysts say about PCYS stock?
As of March 17, 2026, there is no available analyst coverage for PCYS stock. Given its OTC listing and small market capitalization, the company may not attract significant analyst attention.
Investors should conduct their own due diligence and carefully consider the company's financial performance, growth prospects, and risk factors before making any investment decisions. Key valuation metrics, such as P/E ratio and profit margin, indicate significant financial challenges.
What are the main risks for PCYS?
The main risks for PCYS include its negative profit and gross margins, which raise concerns about its financial sustainability. The company also faces intense competition from larger, more established players in the healthcare information services market.
Additionally, as an OTC-listed company, PCYS is subject to liquidity constraints and limited regulatory oversight.
¿Cuáles son los factores clave para evaluar PCYS?
Evaluar PCYS implica revisar los fundamentales, el consenso de analistas y los factores de riesgo. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de PCYS?
El MoonshotScore califica a PCYS de 0 a 100 en salud financiera, impulso del mercado y factores de riesgo. Puntuaciones superiores a 70 indican calificaciones más altas, 50-70 moderadas y por debajo de 50 calificaciones más bajas.
Se actualiza a medida que se renuevan los datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de PCYS?
El precio de PCYS se actualizó por última vez el 8 ago 2026 y se refresca al visualizar la página durante el horario del mercado estadounidense; no es una cotización en tiempo real.
Los fundamentales se actualizan tras los informes trimestrales; el MoonshotScore se recalcula cada noche; las noticias se agregan continuamente.
¿Cuál es la relación P/E de PCYS?
La relación P/E para PCYS compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor.
Consulte la pestaña de Financieros para métricas actuales.
¿Está PCYS sobrevalorada o infravalorada?
Determinar si PrimeCare Systems, Inc. (PCYS) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de PCYS?
PrimeCare Systems, Inc. (PCYS) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Datos proporcionados solo con fines informativos.